SOURCES SOUGHT: Mass Spectrometry Reagents
ID: 75N95025Q00118Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/13611400fcae4e18b4aa1a7314555177/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), is seeking qualified small business sources for the procurement of specialized Mass Spectrometry Reagents aimed at advancing research on Alzheimer’s Disease and related dementias. The objective is to establish a national resource of isogenic induced pluripotent stem cell (iPSC) lines to study genetic mutations associated with these diseases, thereby accelerating mechanistic discovery. This procurement is critical for enhancing the understanding of Alzheimer’s disease mechanisms and includes specific requirements for HPLC columns and related supplies, with the first delivery expected by July 7, 2025, and additional options extending to July 2027. Interested parties should submit their capability statements to Rashiid Cummins at Rashiid.Cummins@nih.gov by January 21, 2025, at 3:00 PM Eastern Time.

    Point(s) of Contact
    Rashiid Cummins
    rashiid.cummins@nih.gov
    Files
    Title
    Posted
    PURCHASE DESCRIPTION Mass Spectrometry Reagents.pdf
    The National Institute on Aging (NIA) is issuing a request for proposals (RFP) for the procurement of specialized Mass Spectrometry Reagents targeted at advancing research on Alzheimer’s Disease and related dementias. The goal is to establish a national resource of isogenic iPSC lines for the study of genetic mutations connected to these diseases, aimed at accelerating mechanistic discovery. Key products required include specific HPLC columns and related supplies from ThermoFisher, with detailed specifications outlined for each item. The quantities specified for delivery are set for various deadlines, with the first batch needed by July 7, 2025, followed by additional options extending to July 2027. All delivered items must meet government packaging and quality specifications to ensure readiness for immediate use. Overall, this procurement effort reflects a strategic initiative by the NIA to foster research that could provide critical insights into Alzheimer’s disease mechanisms.
    Lifecycle
    Title
    Type
    SOURCES SOUGHT: Mass Spectrometry Reagents
    Currently viewing
    Sources Sought
    Similar Opportunities
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for measuring abeta42, abeta40, and pTau 217, which will support ongoing research into cognitive decline and neurodegeneration using samples from the Baltimore Longitudinal Study of Aging. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on January 15, 2025, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547. This procurement is conducted under simplified acquisition procedures and is open to all qualified offerors without set-aside restrictions.
    Maintenance service for Mass Spectrometers and components
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide maintenance services for Mass Spectrometers and associated components utilized by the National Institute on Aging (NIA). The procurement aims to ensure the proper functioning of critical instruments, including the Q Exactive HF and Orbitrap Eclipse Tribid, which are essential for ongoing research in discovery proteomics and aging studies. Interested vendors must submit a capability statement detailing their qualifications, including employee numbers and relevant experience, by January 17, 2025, at 5:00 PM EST, to Iris Merscher at iris.merscher@nih.gov. This notice is a Sources Sought announcement and does not constitute a solicitation for proposals.
    SOURCES SOUGHT: Automated Cell Dissociation Apparatus
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an automated cell dissociation apparatus for the National Institute on Aging's Laboratory of Neurogenetics. The primary objective of this procurement is to acquire equipment capable of isolating single nuclei from human and mouse brain tissues, which is crucial for advancing research on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease. The preferred model for this apparatus is the S2 Genomics Singulator 100 Cell Dissociation Platform, which must meet specific requirements including bench-top compatibility, single-use cartridges, and customizable software for protocol adjustments. Interested companies must submit their capability statements by January 17, 2025, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring they include all necessary documentation and adhere to the specified format.
    Cambridge Isotope L-Glutamine
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide L-Glutamine enriched with stable isotope 13C for neuroscience research. The procurement aims to secure domestically manufactured chemicals that are essential for enhancing carbon-13 MR spectroscopy signals, which are critical for studying brain metabolism and measuring important metabolites. This initiative underscores the importance of maintaining a domestic supply of these chemicals to support ongoing research efforts at NIH and NIMH. Interested parties must submit their responses, including company information and capability statements, electronically to Joseph Kennedy at joseph.kennedy@nih.gov by January 22, 2025, as the anticipated contract duration is 12 months.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug products. The objective of this procurement is to secure high-quality formulated drug products to support preclinical, IND-enabling, and clinical studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is critical for advancing therapeutic development and enhancing the drug development pipeline, which is vital for public health. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can reach out to Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Biological Therapeutics Product Development Subject Matter Expert Consultants
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for consulting services from subject matter expert (SME) consultants to support the development of biological therapeutics. The primary objective is to engage experts who can provide technical recommendations across various phases of drug discovery and development, including chemistry, regulatory affairs, and clinical trial design, particularly for novel therapeutics aimed at neurological disorders and rare genetic conditions. This initiative is crucial for advancing NIH's drug discovery programs, ensuring that innovative biologics progress efficiently through clinical evaluation. Interested vendors should note that the contract has a performance period of one year, with two optional extensions, and proposals must be submitted by January 27, 2025. For further inquiries, potential bidders can contact Shayna Simpson at shayna.simpson@nih.gov or Kelly Dempsey at kelly.dempsey@nih.gov.
    Acquisition of SomaScan 7K and 11K Assay Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure fifty-nine (59) SomaScan 7K and/or 11K Assay Kits on a sole source basis from SomaLogic Operating Co., Inc. This acquisition is intended to support the Center for Human Immunology, Inflammation, and Autoimmunity (CHI) in their systems biology research, which involves measuring a wide range of proteins in various human biological samples to enhance understanding of the immune system and related diseases. The procurement aligns with federal initiatives to advance health science research capabilities, with an estimated delivery date for the products set for December 20, 2024, and a performance period from February 21, 2025, to February 20, 2026. Interested vendors may contact Kathy Song at kathy.song@nih.gov for further information and must submit their capabilities statements within 15 days of this notice.
    Fieldline 64 Sensor
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide equipment and services for the development of a non-invasive magnetocardiography (MCoG) array, focusing on the Fieldline V3 Sensor. The project aims to enhance the measurement of human neurophysiology by supplying 64 sensors and related hardware, as well as research and design services, including the prototyping of a compound gradiometer. This initiative is critical for advancing the understanding of brain function through improved non-invasive observation techniques. Interested parties must submit their qualifications and capabilities by January 22, 2025, and can contact Joseph Kennedy at joseph.kennedy@nih.gov or Marlene Milgram at marlene.milgram@nih.gov for further information.